Sanchez Ramiro

Alto Neuroscience, Inc. · Director

Sanchez Ramiro is listed in public filings as director. This Sanchez Ramiro insider trading page organizes Form 4 disclosures, reported purchases and sales, transaction dates, share amounts, related issuers, and historical insider activity so readers can review the person's public trading record in one place. Companies and tickers connected to this insider trading profile include Alto Neuroscience, Inc. (ANRO), Rapport Therapeutics, Inc. Common Stock (RAPP), and Cerevel Therapeutics Holdings, Inc. (CERE). Investors use Sanchez Ramiro's insider trading disclosures to study buying and selling patterns, position changes, company-specific activity, and the source evidence behind each reported transaction.

Latest Actions

CompanyHolding ValueLast TransactionAmountTransaction PriceCurrent Price
Alto Neuroscience, Inc.ANRO$270k11k sharesGrant / ExerciseMay 12, 2026$269.9K11k shares$24.63--

Insider Trades History

CompanyHolding ValueLast TransactionAmountTransaction PriceCurrent Price
Alto Neuroscience, Inc.ANRO$63k3.8k sharesGrant / ExerciseJan 2, 2026$63.1K3.8k shares$16.59--
Alto Neuroscience, Inc.ANRO$97k30.6k sharesGrant / ExerciseAug 12, 2025$97.2K30.6k shares$3.18--
Alto Neuroscience, Inc.ANRO$12k3.9k sharesGrant / ExerciseAug 12, 2025$12.5K3.9k shares$3.18--
Rapport Therapeutics, Inc. Common StockRAPP$120k10.9k sharesGrant / ExerciseJun 17, 2025$119.6K10.9k shares$10.95--
Rapport Therapeutics, Inc. Common StockRAPP$800k29.8k sharesGrant / ExerciseNov 7, 2024$800.4K29.8k shares$26.90--
Cerevel Therapeutics Holdings, Inc.CERE$014.7k sharesOtherAug 1, 2024$660.3K14.7k shares$45.00--
Cerevel Therapeutics Holdings, Inc.CERE--87.6k sharesOtherAug 1, 2024Disclosure amount unavailable87.6k shares----
Cerevel Therapeutics Holdings, Inc.CERE--1.4M sharesOtherAug 1, 2024Disclosure amount unavailable1.4M shares----